Tissue chips: advancing disease modeling and drug discovery
A partnership between the National Institutes of Health (NIH), US Food and Drug Administration (FDA) and the Defense Advanced Research Projects Agency (DARPA)… Read more »
Latest posts by Philippa Locke (see all)
- Tissue chips: advancing disease modeling and drug discovery - 20th February 2014
- Equine regenerative medicine: yay or neigh? - 3rd February 2014
- Cardiovascular regeneration – a thematic series edited by Prof Ronald Li - 29th April 2013
Equine regenerative medicine: yay or neigh?
Horses have long been admired for their beauty, spirit, strength and speed. While a dog might be man’s best friend, the horse has been a near essential… Read more »
Cardiovascular regeneration – a thematic series edited by Prof Ronald Li
Stem Cell Research & Therapy, is now accepting research submissions for consideration in a special series focusing on cardiovascular regeneration. The… Read more »
Nobel prize winners a beacon for stem cell research
Congratulations from all at BioMed Central to Sir John Gurdon and Shinya Yamanaka, who share the 2012 Nobel prize in physiology or medicine for “the discovery… Read more »
Clinical applications of stem cells: a new series from Stem Cell Research & Therapy
The progress made and problems faced in taking stem cells from the lab to the clinic is the focus of a new thematic series on clinical applications of stem… Read more »
Stem cell research in the Asia-Pacific: call for papers
Stem Cell Research & Therapy invites the submission of original research manuscripts for inclusion in a special series on stem cell research in the… Read more »
Stem Cell Research & Therapy tracked by Thomson Reuters
Stem Cell Research & Therapy is expected to receive its first Impact Factor in June 2012, having been accepted for tracking by Thomson Reuters (ISI). The… Read more »
Stem Cell Research & Therapy's first year
Stem Cell Research & Therapy, the home of translational research into stem cell therapeutics, recently celebrated its first anniversary. In an editorial… Read more »